| http://www.w3.org/ns/prov#value | - Furthermore, given that mutations and other abnormalities relevant to the function of the dopamine transporter (DAT) have been linked to both bipolar mania28- 32 and schizophrenia30,31 and that amphetamine preferentially inhibits the norepinephrine transporter,33 we assessed the potential of genetic and selective pharmacologic manipulations of the DAT to mimic the patterns exhibited by patients wi
|
